Glenmark Pharmaceuticals shareholding pattern

GLENMARK

HealthcareLarge

2044.9

15.60 (0.77%)
Last updated on 14 Aug, 2025 | 15:30 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Glenmark Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

46.65%

Mutual Fund

15.55%

Insurance

0.46%

Foreign Institutional Investors

20.62%

Domestic Institutional Investors

1.67%

Retail

15.06%

Others

-0.01%

Total Promoters
MAR '25
46.65%
JUN '25
46.65%

Glenmark Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Glenmark Pharmaceuticals stands at 46.65% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Glenmark Pharmaceuticals is 20.62% and 1.67% respectively.

The retail shareholding of the Glenmark Pharmaceuticals is 15.06%.

Changes in shareholding patterns of Glenmark Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Glenmark Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.